1. Shapiro SM. Bilirubin toxicity in the developing nervous system.Pediatr Neurol 2003; 29: 410-421.
2. Amin SB, Lamola AA.Newborn jaundice Technologies: unbound bilirubin and bilirubin binding capacity in neonates. Semin Perinatol 2011; 35: 134-140.
3. NICE. Jaundice in newborn babies under 28 days. Clinical guideline 2014 NCC-WCH 2014; 1: 1-54.
4. Maisels M, Watchko J. Treatment of jaundice in low birthweight infants. Fetal Neonatal 2003; 88: 459-463.
5. NVK. Conceptrichtlijnen hyperbilirubinemie. Nederlandse vereniging voor kindergeneeskunde 2007; 1: 1-103.
6. Clukers J, Van Gaal PJ. Opstellen van neonatale referentiewaarden voor vrij bilirubine, gemeten met een nieuwe methode en correlatie aan automated auditory brainstem response (AABR) en studie van de in vivo verplaatsing van vrij bilirubine in serum, voor en na toediening van ibuprofen, op ingevroren stalen van prematuren 2012.
7. William Oh, Stevenson DK, Tyson JE. Influence of the clinical status on the association between plasma total and unbound bilirubine and adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatr 2010; 99: 673-8.
8. Ahlfors CE. Measurement of Plasma Unbound Unconjugated Bilirubin. Analytical Biochemistry 2000; 279: 130–5.
9. Van Hoof, VO. Development and validation of a new, direct and simple method to quantify free bilirubin, a biomarker of bilirubin induced neurotoxicity. Clinical Chemistry 2009; 55: A234-A234.
10. Robertson A, Karp W, Brodersen R. Bilirubin displacing effect of drugs used in neonatology. Acta Paediatr Scand 1991; 80: 1119-1127.
11. Brodersen R. Competitive Binding of Bilirubin and Drugs to Human Serum Albumin Studied by Enzymatic Oxidation. The Journal of Clinical Investigation 1974; 54: 1353-1364.
12. Bertholf RL. Determining Laboratory Reference Intervals: CLSI Guideline Makes the Task Manageable. Lab Medicine 2009; 40: 75-76.
13. Amin, A.C. Effect of storage and freezing unbound bilirubin measurement. Clinica Chimica Acta 2008; 396: 56-57.
14. Fevery J. Bilirubin in clinical practive: a review. Liver Int. 2008; 28: 92-605.
15. Van Hoof V, Devos H, Persy B, Naesens R, Wendelen L, Meel M, et al. Development and validation of a direct and simple method to isolate and quantify Free Bilirubin, a Biomarker of Bilirubin Induces Neurotoxicity. Clinical Chemistry, 2009; 55: A234.
16. Gray R. Kinetics and mechanism of bilirubin binding to human serum albumin. Journal of biological chemistry 1978; 253: 4370-7377.